Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.843,12
-0,61%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Daxor Corporation (DXR) Daxor Corporation (DXR) Notizie

DXR

Daxor (DXR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DXR
DataOraFonteTitoloSimboloCompagnia
16/04/202414:00GlobeNewswire Inc.New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionNASDAQ:DXRDaxor Corporation
15/04/202414:00GlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)NASDAQ:DXRDaxor Corporation
10/04/202414:00GlobeNewswire Inc.Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalNASDAQ:DXRDaxor Corporation
01/04/202414:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24NASDAQ:DXRDaxor Corporation
25/03/202413:00GlobeNewswire Inc.Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsNASDAQ:DXRDaxor Corporation
22/03/202413:00GlobeNewswire Inc.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024NASDAQ:DXRDaxor Corporation
18/03/202419:18GlobeNewswire Inc.Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023NASDAQ:DXRDaxor Corporation
18/03/202419:18GlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersNASDAQ:DXRDaxor Corporation
11/03/202413:00GlobeNewswire Inc.Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User BaseNASDAQ:DXRDaxor Corporation
08/03/202419:49Edgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
08/03/202414:00GlobeNewswire Inc.Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsNASDAQ:DXRDaxor Corporation
06/03/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
29/02/202422:15Edgar (US Regulatory)Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report)NASDAQ:DXRDaxor Corporation
26/02/202414:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:DXRDaxor Corporation
12/02/202414:00GlobeNewswire Inc.Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsNASDAQ:DXRDaxor Corporation
07/02/202414:00GlobeNewswire Inc.Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsNASDAQ:DXRDaxor Corporation
29/01/202414:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingNASDAQ:DXRDaxor Corporation
16/01/202414:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressNASDAQ:DXRDaxor Corporation
09/01/202414:00GlobeNewswire Inc.DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESNASDAQ:DXRDaxor Corporation
02/01/202414:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
02/01/202414:30GlobeNewswire Inc.Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
24/11/202319:53Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
13/11/202314:00GlobeNewswire Inc.New Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure PatientsNASDAQ:DXRDaxor Corporation
09/11/202314:00GlobeNewswire Inc.Daxor Corporation Awarded New Patent for Remote Monitoring of Blood VolumeNASDAQ:DXRDaxor Corporation
13/10/202314:00GlobeNewswire Inc.Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific MeetingNASDAQ:DXRDaxor Corporation
11/10/202314:00GlobeNewswire Inc.New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific MeetingNASDAQ:DXRDaxor Corporation
04/10/202314:00GlobeNewswire Inc.Daxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services ProgramNASDAQ:DXRDaxor Corporation
27/09/202314:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023NASDAQ:DXRDaxor Corporation
26/09/202315:14Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]NASDAQ:DXRDaxor Corporation
26/09/202314:00GlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)NASDAQ:DXRDaxor Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DXR

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network